177 related articles for article (PubMed ID: 36766518)
1. Development and External Validation of a Radiomics Model Derived from Preoperative Gadoxetic Acid-Enhanced MRI for Predicting Histopathologic Grade of Hepatocellular Carcinoma.
Hu X; Li C; Wang Q; Wu X; Chen Z; Xia F; Cai P; Zhang L; Fan Y; Ma K
Diagnostics (Basel); 2023 Jan; 13(3):. PubMed ID: 36766518
[TBL] [Abstract][Full Text] [Related]
2. Hepatocellular carcinoma pathologic grade prediction using radiomics and machine learning models of gadoxetic acid-enhanced MRI: a two-center study.
Han YE; Cho Y; Kim MJ; Park BJ; Sung DJ; Han NY; Sim KC; Park YS; Park BN
Abdom Radiol (NY); 2023 Jan; 48(1):244-256. PubMed ID: 36131163
[TBL] [Abstract][Full Text] [Related]
3. A radiomics-based biomarker for cytokeratin 19 status of hepatocellular carcinoma with gadoxetic acid-enhanced MRI.
Wang W; Gu D; Wei J; Ding Y; Yang L; Zhu K; Luo R; Rao SX; Tian J; Zeng M
Eur Radiol; 2020 May; 30(5):3004-3014. PubMed ID: 32002645
[TBL] [Abstract][Full Text] [Related]
4. Gadoxetic Acid-Enhanced MRI-Based Radiomics Signature: A Potential Imaging Biomarker for Identifying Cytokeratin 19-Positive Hepatocellular Carcinoma.
Hu X; Wang Q; Huang G; He X; Sparrelid E; Brismar TB; Fan Y
Comput Math Methods Med; 2023; 2023():5424204. PubMed ID: 36814805
[TBL] [Abstract][Full Text] [Related]
5. Radiomics and nomogram of magnetic resonance imaging for preoperative prediction of microvascular invasion in small hepatocellular carcinoma.
Chen YD; Zhang L; Zhou ZP; Lin B; Jiang ZJ; Tang C; Dang YW; Xia YW; Song B; Long LL
World J Gastroenterol; 2022 Aug; 28(31):4399-4416. PubMed ID: 36159011
[TBL] [Abstract][Full Text] [Related]
6. Considerable effects of imaging sequences, feature extraction, feature selection, and classifiers on radiomics-based prediction of microvascular invasion in hepatocellular carcinoma using magnetic resonance imaging.
Dai H; Lu M; Huang B; Tang M; Pang T; Liao B; Cai H; Huang M; Zhou Y; Chen X; Ding H; Feng ST
Quant Imaging Med Surg; 2021 May; 11(5):1836-1853. PubMed ID: 33936969
[TBL] [Abstract][Full Text] [Related]
7. Radiomics model based on preoperative gadoxetic acid-enhanced MRI for predicting liver failure.
Zhu WS; Shi SY; Yang ZH; Song C; Shen J
World J Gastroenterol; 2020 Mar; 26(11):1208-1220. PubMed ID: 32231424
[TBL] [Abstract][Full Text] [Related]
8. Preoperative Prediction of Cytokeratin 19 Expression for Hepatocellular Carcinoma with Deep Learning Radiomics Based on Gadoxetic Acid-Enhanced Magnetic Resonance Imaging.
Chen Y; Chen J; Zhang Y; Lin Z; Wang M; Huang L; Huang M; Tang M; Zhou X; Peng Z; Huang B; Feng ST
J Hepatocell Carcinoma; 2021; 8():795-808. PubMed ID: 34327180
[TBL] [Abstract][Full Text] [Related]
9. Predicting the grade of hepatocellular carcinoma based on non-contrast-enhanced MRI radiomics signature.
Wu M; Tan H; Gao F; Hai J; Ning P; Chen J; Zhu S; Wang M; Dou S; Shi D
Eur Radiol; 2019 Jun; 29(6):2802-2811. PubMed ID: 30406313
[TBL] [Abstract][Full Text] [Related]
10. Multiphase MRI-Based Radiomics for Predicting Histological Grade of Hepatocellular Carcinoma.
Yan Y; Si Z; Chun C; Chao-Qun P; Ke M; Dong Z; Li W
J Magn Reson Imaging; 2024 Feb; ():. PubMed ID: 38344854
[TBL] [Abstract][Full Text] [Related]
11. Gd-EOB-DTPA-enhanced MRI radiomic features for predicting histological grade of hepatocellular carcinoma.
Mao Y; Wang J; Zhu Y; Chen J; Mao L; Kong W; Qiu Y; Wu X; Guan Y; He J
Hepatobiliary Surg Nutr; 2022 Feb; 11(1):13-24. PubMed ID: 35284527
[TBL] [Abstract][Full Text] [Related]
12. Preoperative prediction for pathological grade of hepatocellular carcinoma via machine learning-based radiomics.
Mao B; Zhang L; Ning P; Ding F; Wu F; Lu G; Geng Y; Ma J
Eur Radiol; 2020 Dec; 30(12):6924-6932. PubMed ID: 32696256
[TBL] [Abstract][Full Text] [Related]
13. MRI-Radiomics Prediction for Cytokeratin 19-Positive Hepatocellular Carcinoma: A Multicenter Study.
Yang F; Wan Y; Xu L; Wu Y; Shen X; Wang J; Lu D; Shao C; Zheng S; Niu T; Xu X
Front Oncol; 2021; 11():672126. PubMed ID: 34476208
[TBL] [Abstract][Full Text] [Related]
14. Radiomics Model Based on Gadoxetic Acid Disodium-Enhanced MR Imaging to Predict Hepatocellular Carcinoma Recurrence After Curative Ablation.
Zhang L; Cai P; Hou J; Luo M; Li Y; Jiang X
Cancer Manag Res; 2021; 13():2785-2796. PubMed ID: 33790652
[TBL] [Abstract][Full Text] [Related]
15. Preoperative Gadoxetic Acid-Enhanced MRI Based Nomogram Improves Prediction of Early HCC Recurrence After Ablation Therapy.
Hu C; Song Y; Zhang J; Dai L; Tang C; Li M; Liao W; Zhou Y; Xu Y; Zhang YY; Zhou Y
Front Oncol; 2021; 11():649682. PubMed ID: 34094938
[TBL] [Abstract][Full Text] [Related]
16. LI-RADS category 5 hepatocellular carcinoma: preoperative gadoxetic acid-enhanced MRI for early recurrence risk stratification after curative resection.
Wei H; Jiang H; Zheng T; Zhang Z; Yang C; Ye Z; Duan T; Song B
Eur Radiol; 2021 Apr; 31(4):2289-2302. PubMed ID: 33001306
[TBL] [Abstract][Full Text] [Related]
17. Predictive models and early postoperative recurrence evaluation for hepatocellular carcinoma based on gadoxetic acid-enhanced MR imaging.
Li Q; Wei Y; Zhang T; Che F; Yao S; Wang C; Shi D; Tang H; Song B
Insights Imaging; 2023 Jan; 14(1):4. PubMed ID: 36617581
[TBL] [Abstract][Full Text] [Related]
18. A radiomics model based on preoperative gadoxetic acid-enhanced magnetic resonance imaging for predicting post-hepatectomy liver failure in patients with hepatocellular carcinoma.
Li C; Wang Q; Zou M; Cai P; Li X; Feng K; Zhang L; Sparrelid E; Brismar TB; Ma K
Front Oncol; 2023; 13():1164739. PubMed ID: 37476376
[TBL] [Abstract][Full Text] [Related]
19. Preoperative contrast-enhanced computed tomography-based radiomics model for overall survival prediction in hepatocellular carcinoma.
Deng PZ; Zhao BG; Huang XH; Xu TF; Chen ZJ; Wei QF; Liu XY; Guo YQ; Yuan SG; Liao WJ
World J Gastroenterol; 2022 Aug; 28(31):4376-4389. PubMed ID: 36159012
[TBL] [Abstract][Full Text] [Related]
20. Radiomic analysis of Gd-EOB-DTPA-enhanced MRI predicts Ki-67 expression in hepatocellular carcinoma.
Fan Y; Yu Y; Wang X; Hu M; Hu C
BMC Med Imaging; 2021 Jun; 21(1):100. PubMed ID: 34130644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
